Novozymes AS Profile

USD 0.95  1.84%

Novozymes AS Summary

Novozymes AS (NVZMF) is traded on OTC Market in USA. It is located in Krogshoejvej 36 and employs 5,973 people. The company currently falls under 'Large-Cap' category with current market capitalization of 14.58 B. Novozymes AS has 295.2 M outstanding shares. NOVOZYMES A/S has accumulated about 104.21 M in cash with 669.95 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Check Novozymes AS Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 50.64HorizonTargetOdds Above 50.64
0.80%30 days 50.64 99.16%
Based on normal probability distribution, the odds of Novozymes AS to move above current price in 30 days from now is close to 99% (This Novozymes AS probability density function shows the probability of Novozymes AS Stock to fall within a particular range of prices over 30 days) .

Top Holders

Novozymes AS Risk Profiles

Key Fundamentals

Novozymes AS Against Markets

Current Ratings

Novozymes AS 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Novozymes AS are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Novozymes AS produces and sells industrial enzymes and microorganisms worldwide. Novozymes AS was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes AS is traded on OTC Market in USA. more
NameNovozymes AS
CEO and PresPeder NielsenView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressKrogshoejvej 36
ExchangeOTC Market
Phone45 44 46 00 00
CurrencyUSD - US Dollar


Novozymes AS Corporate Directors
Kasim Kutay Director
Agnete RaaschouNielsen Director
Joergen Rasmussen Independent Director
Please see also Stocks Correlation. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.